MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 74 filers reported holding MEREO BIOPHARMA GROUP PLC in Q4 2021. The put-call ratio across all filers is 4.68 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $3,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tejara Capital Ltd | 3,215,001 | $4,147,351 | 2.35% |
| Soleus Capital Management, L.P. | 9,677,419 | $12,483,871 | 1.15% |
| 683 Capital Management, LLC | 6,000,000 | $7,740,000 | 0.60% |
| Rubric Capital Management LP | 11,616,120 | $14,984,795 | 0.56% |
| MANGROVE PARTNERS IM, LLC | 5,531,547 | $7,135,696 | 0.54% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 7,364,438 | $9,500,125 | 0.51% |
| DAFNA Capital Management LLC | 962,513 | $1,241,642 | 0.39% |
| Clearline Capital LP | 3,102,723 | $4,002,512 | 0.34% |
| Rock Springs Capital Management LP | 7,676,481 | $9,902,660 | 0.26% |
| Monaco Asset Management SAM | 595,729 | $768,490 | 0.23% |